NASDAQ
1.00USD
0.00 (0.00%)
We have scored 3 news catalysts on Angion Biomedica Corp. (ANGN) over the past 12 months. Coverage across the window leans positive (average ticker sentiment +0.13). Most of the impact sits in price momentum and sector healthcare.
Market cap
30.1M
P/E
—
EPS
—
Beta
0.60
52W range
1.0-20.4
Day range
1.00–1.00
Open
1.06
Prev close
1.00
Volume
224.8K
Avg volume
9.6K
Dividend
0.00
IPO
2021-02-05
No scored news tagged ANGN or its network in the window yet.
Show more ANGN articles →Angion Biomedica Corp. operates as a biopharmaceutical enterprise, concentrating its efforts on the identification, advancement, and market introduction of small molecule treatments for severe organ damage and scarring conditions. Its primary investigational compound, ANG-3070, is an orally administered tyrosine kinase receptor inhibitor currently being developed to address fibrotic ailments, particularly those impacting the kidneys and lungs. The company's product pipeline also features ANG-3777, a hepatocyte growth factor mimetic engineered to treat acute organ injuries like delayed graft function, in addition to initiatives for ROCK2 inhibitors targeting fibrotic diseases and a CYP11B2 inhibitor program. Established in 1998, Angion Biomedica Corp. maintains its headquarters in Uniondale, New York.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Angion Biomedica Corp. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for ANGN: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
